Elite Pharmaceuticals (ELTP) Receivables (2011 - 2026)
Elite Pharmaceuticals (ELTP) posted Receivables of $50.44 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 39.3% from $36.22 million a year earlier but down 15.5% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Receivables (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Receivables came in at $59.72 million, up 104.5% from FY2025.
- Annual Receivables has increased for four consecutive fiscal years, with a five-year compound annual growth rate of 76.4% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' Receivables was $29.21 million in FY2025 (+50.1%), $19.45 million in FY2024 (+528.6%), $3.09 million in FY2023 (+1.2%) and $3.06 million in FY2022 (-12.5%).
- Quarterly Receivables has run from a low of $2.66 million in fiscal Q3 2022 to a high of $59.72 million in fiscal Q4 2026 over five years.
- On a year-over-year basis, Receivables has increased in each of the last 15 quarters, with growth averaging 80.5% over the last eight quarters.
- The strongest year-over-year quarter for Receivables in the past five years was fiscal Q4 2024, with growth of 528.6%; the weakest was fiscal Q3 2022, with a decline of 19.3%.
- According to Business Quant data, Receivables for the three prior fiscal quarters was $59.72 million (Q4 2026), $48.53 million (Q3 2026) and $40.87 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 50.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.44 Mn |
| Mar 31, 2026 | 59.72 Mn |
| Dec 31, 2025 | 48.53 Mn |
| Sep 30, 2025 | 40.87 Mn |
| Jun 30, 2025 | 36.22 Mn |
| Mar 31, 2025 | 29.21 Mn |
| Dec 31, 2024 | 18.45 Mn |
| Sep 30, 2024 | 21.44 Mn |
| Jun 30, 2024 | 20.49 Mn |
| Mar 31, 2024 | 19.45 Mn |
| Dec 31, 2023 | 16.01 Mn |
| Sep 30, 2023 | 10.50 Mn |
| Jun 30, 2023 | 6.20 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 5.55 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 3.97 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 2.66 Mn |
| Sep 30, 2021 | 4.67 Mn |
API Access
Elite Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();